Cargando…
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome
BACKGROUND: Literature is inconclusive regarding the association between antiplatelet agents use and outcome after aneurysmal subarachnoid hemorrhage. AIMS: To investigate the association between clinical outcome and prehemorrhage use in aneurysmal subarachnoid hemorrhage patients as well as the imp...
Autores principales: | Sebök, Martina, Hostettler, Isabel C, Keller, Emanuela, Rautalin, Ilari M, Coert, Bert A, Vandertop, William P, Post, René, Sardeha, Ali, Tjerkstra, Maud A, Regli, Luca, Verbaan, Dagmar, Germans, Menno R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150139/ https://www.ncbi.nlm.nih.gov/pubmed/34282988 http://dx.doi.org/10.1177/17474930211035647 |
Ejemplares similares
-
Aneurysm treatment within 6 h versus 6–24 h after rupture in patients with subarachnoid hemorrhage
por: Vergouwen, Mervyn DI, et al.
Publicado: (2023) -
Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
por: Germans, Menno R, et al.
Publicado: (2013) -
Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan
por: Post, René, et al.
Publicado: (2020) -
Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review
por: Tjerkstra, Maud A., et al.
Publicado: (2023) -
Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
por: Rautalin, Ilari M., et al.
Publicado: (2019)